Finerenone
Finerenone (BAY 94-8862) is a third-generation, selective, and orally available nonsteroidal mineralocorticoid receptor (MR) antagonist (IC50=18 nM) . Finerenone displays excellent selectivity versus glucocorticoid receptor (GR), androgen receptor (AR), and progesterone receptor (>500-fold) . Finerenone has the potential for cardiorenal diseases research, such as type 2 diabetes mellitus and chronic kidney disease[1][2].
Product Specifications
CAS Number
1050477-31-0
Product Name Alternative
BAY 94-8862
UNSPSC
12352005
Hazard Statement
H315, H319
Target
Mineralocorticoid Receptor
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/finerenone.html
Purity
99.95
Solubility
DMSO : 70 mg/mL (ultrasonic)
Smiles
O=C(C1=C(C)NC2=C(C(OCC)=NC=C2C)[C@@H]1C3=CC=C(C#N)C=C3OC)N
Molecular Formula
C21H22N4O3
Molecular Weight
378.42
Precautions
H315, H319
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
HRP-Linked Monoclonal Antibody to Follicle Stiulating Hormone Beta (FSHb)
HRP-Linked Monoclonal Antibody to Follicle Stiulating Hormone Beta (FSHb)
HRP-Linked Monoclonal Antibody to Follicle Stiulating Hormone Beta (FSHb)